Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 1
2016 2
2017 2
2018 4
2019 4
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma.
Iacono D, Basile D, Gerratana L, Vitale MG, Pelizzari G, Cinausero M, Poletto E, Puglisi F, Fasola G, Minisini AM. Iacono D, et al. Among authors: poletto e. Melanoma Res. 2019 Oct;29(5):510-515. doi: 10.1097/CMR.0000000000000584. Melanoma Res. 2019. PMID: 30702508
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy.
Ongaro E, Gerratana L, Cinausero M, Pelizzari G, Poletto E, Giangreco M, Andreetta C, Pizzolitto S, Di Loreto C, Minisini AM, Mansutti M, Russo S, Fasola G, Puglisi F. Ongaro E, et al. Among authors: poletto e. Future Oncol. 2018 Apr;14(9):849-859. doi: 10.2217/fon-2017-0384. Epub 2018 Mar 12. Future Oncol. 2018. PMID: 29527957
Immunotherapy for older patients with melanoma: From darkness to light?
Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: poletto e. Pigment Cell Melanoma Res. 2020 Aug 3. doi: 10.1111/pcmr.12917. Online ahead of print. Pigment Cell Melanoma Res. 2020. PMID: 32745351 Review.
Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, Puglisi F. Bonotto M, et al. Among authors: poletto e. Clin Breast Cancer. 2013 Jun;13(3):167-72. doi: 10.1016/j.clbc.2012.10.002. Epub 2012 Dec 5. Clin Breast Cancer. 2013. PMID: 23218471 Review.
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach.
Garziera M, Roncato R, Montico M, De Mattia E, Gagno S, Poletto E, Scalone S, Canzonieri V, Giorda G, Sorio R, Cecchin E, Toffoli G. Garziera M, et al. Among authors: poletto e. Cells. 2019 Jun 14;8(6):584. doi: 10.3390/cells8060584. Cells. 2019. PMID: 31197119 Free PMC article.
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
Gagno S, Poletto E, Bartoletti M, Quartuccio L, Romualdi C, Garziera M, Scalone S, Sorio R, Dreussi E, Zanusso C, De Mattia E, Roncato R, Cecchin E, Giorda G, De Vita S, Dal Bo M, Puglisi F, Toffoli G. Gagno S, et al. Among authors: poletto e. Gynecol Oncol. 2020 Jan;156(1):233-242. doi: 10.1016/j.ygyno.2019.10.019. Epub 2019 Nov 9. Gynecol Oncol. 2020. PMID: 31711657
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).
Garziera M, Cecchin E, Canzonieri V, Sorio R, Giorda G, Scalone S, De Mattia E, Roncato R, Gagno S, Poletto E, Romanato L, Sartor F, Polesel J, Toffoli G. Garziera M, et al. Among authors: poletto e. Int J Mol Sci. 2018 May 18;19(5):1510. doi: 10.3390/ijms19051510. Int J Mol Sci. 2018. PMID: 29783665 Free PMC article.
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC).
Garziera M, Cecchin E, Giorda G, Sorio R, Scalone S, De Mattia E, Roncato R, Gagno S, Poletto E, Romanato L, Ecca F, Canzonieri V, Toffoli G. Garziera M, et al. Among authors: poletto e. Cells. 2019 Oct 1;8(10):1186. doi: 10.3390/cells8101186. Cells. 2019. PMID: 31581548 Free PMC article.
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.
Martel S, Poletto E, Ferreira AR, Lambertini M, Sottotetti F, Bertolini I, Montemurro F, Bernardo A, Risi E, Zanardi E, Ziliani S, Mura S, Dellepiane C, Del Mastro L, Minisini AM, Puglisi F. Martel S, et al. Among authors: poletto e. Breast. 2018 Feb;37:142-147. doi: 10.1016/j.breast.2017.11.004. Epub 2017 Nov 21. Breast. 2018. PMID: 29161652
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M, Ferreira AR, Di Meglio A, Poggio F, Puglisi F, Sottotetti F, Montemurro F, Poletto E, Bernardo A, Risi E, Dellepiane C, Sini V, Minuti G, Grasso D, Fancelli S, Del Mastro L. Lambertini M, et al. Among authors: poletto e. Clin Breast Cancer. 2017 Dec;17(8):601-610.e2. doi: 10.1016/j.clbc.2017.04.002. Epub 2017 Apr 11. Clin Breast Cancer. 2017. PMID: 28479052
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback